Long-term efficacy; anti-TNF-alpha; intravitreal triamcinolone acetonide; human recombinant interferon-alpha-2a; pulmonary artery involvement; nervous system symptoms; cystoid macular edema; double-blind; refractory uveitis; extraocular manifestations; Behcet's disease; anti-TNF; treatment. This evidence concerns the gene TNF and cystoid macular edema.